You have 9 free searches left this month | for more free features.

cabozantinib

Showing 1 - 25 of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

Active, not recruiting
  • Renal Cell Carcinoma
  • Cabozantinib
  • Padova, Italy
    Istituto Oncologico Veneto
Feb 7, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

Not yet recruiting
  • Castration-resistant Prostate Cancer
  • Metastatic Cancer
  • (no location specified)
Aug 12, 2022

Pancreatic Cancer Trial in Lexington (Cabozantinib, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Feb 26, 2022

Carcinoma Prostate Trial in Brescia (Cabozantinib)

Recruiting
  • Carcinoma Prostate
  • Cabozantinib
  • Brescia, Italy
    Alfredo Berruti
Mar 2, 2022

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Cabozantinib
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Cabozantinib
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

Recruiting
  • Neuroblastoma
  • +2 more
  • Cabozantinib
  • Columbus, Ohio
    Nationwide Children's Hospital
Feb 25, 2022

Prostate Cancer Trial in Houston (Cabozantinib, Androgen Ablation Therapy)

Completed
  • Prostate Cancer
  • Cabozantinib
  • Androgen Ablation Therapy
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Meningioma Trial in Miami (Cabozantinib)

Recruiting
  • Meningioma
  • Cabozantinib
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
Jun 17, 2022

High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)

Recruiting
  • High Grade Neuroendocrine Neoplasms
  • Cabozantinib
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 11, 2021

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange (Cabozantinib, Pembrolizumab)

Recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022

Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Cabozantinib
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Breast Cancer Trial in Boston (Nivolumab, Cabozantinib)

Completed
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 29, 2021

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
  • Refractory Soft Tissue Sarcomas
  • Cabozantinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 9, 2021

Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)

Recruiting
  • Germ Cell Tumor
  • +3 more
  • Cabozantinib
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Jun 27, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

Not yet recruiting
  • Neuroendocrine Tumors
  • Portland, Oregon
    Providence Portland Cancer Institute - Franz Clinic
Feb 10, 2022

Advanced Metastatic Melanoma Trial in Iowa City (Cabozantinib, Pembrolizumab)

Recruiting
  • Advanced Metastatic Melanoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

Terminated
  • Glioblastoma Multiforme
  • +3 more
  • Cabozantinib
  • Indianapolis, Indiana
    Riley Hospital for Children at IU Health
Jul 21, 2022

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Tampa, Florida
  • +2 more
Jun 9, 2022

d To Treat People With Hepatocellular Carcinoma

Recruiting
  • Hepatocellular Cancer
  • Cabozantinib
  • Tokyo, Japan
    Takeda Selected Site
Dec 1, 2021

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting
  • Carcinoid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 14, 2022

Hepatocellular Carcinoma, HCC Trial in Orange (Nivolumab, Ipilimumab, Cabozantinib)

Recruiting
  • Hepatocellular Carcinoma
  • HCC
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Apr 4, 2022

Urothelial Carcinoma, Urethral Tumors, Urinary Bladder Tumors Trial run by the NCI (Cabozantinib)

Active, not recruiting
  • Urothelial Carcinoma
  • +3 more
  • Cabozantinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021